Pseudoprotodioscin
CAS: 102115-79-7
Ref. 3D-OP31761
1g | 741,00 € | ||
2g | 2.314,00 € | ||
100mg | 209,00 € | ||
250mg | 363,00 € | ||
500mg | 478,00 € |
Produktinformation
- (3β,25R)-26-(β-<span class="text-smallcaps">D</smallcap>-Glucopyranosyloxy)furosta-5,20(22)-dien-3-yl O-6-deoxy-α-<smallcap>L</smallcap>-mannopyranosyl-(1→2)-O-[6-deoxy-α-<smallcap>L</smallcap>-mannopyranosyl-(1→4)]-β-<smallcap>D</span>-glucopyranoside
- Oligofurostanoside A
- Protodioscin, Pseudo-
- Pseudo-Protodioscin
- Pseudoprototribestin
- β-<span class="text-smallcaps">D</smallcap>-Glucopyranoside, (3β,25R)-26-(β-<smallcap>D</smallcap>-glucopyranosyloxy)furosta-5,20(22)-dien-3-yl O-6-deoxy-α-<smallcap>L</smallcap>-mannopyranosyl-(1→2)-O-[6-deoxy-α-<smallcap>L</span>-mannopyranosyl-(1→4)]-
Pseudoprotodioscin is a soybean extract that has been shown to have anti-inflammatory, anti-atherosclerotic, and anti-autoimmune effects. It is a natural product that belongs to the group of protodioscin derivatives. The cytotoxic effects of pseudoprotodioscin have been studied in 3T3-L1 preadipocytes. This molecule is also an inhibitor of DNA polymerase, which may account for its significant cytotoxic activity against tumor cells. Pseudoprotodioscin has been shown to be effective in the treatment of bowel diseases such as ulcerative colitis and Crohn's disease, as well as prostate cancer. Molecular docking analysis suggests that pseudoprotodioscin binds to the surface of DNA gyrase and prevents it from binding with the complementary strand of DNA during replication. This inhibition leads to cell death by preventing DNA synthesis and cell division.
Chemische Eigenschaften
Technische Anfrage zu: 3D-OP31761 Pseudoprotodioscin
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.